An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
PHASE2
This is an adaptive, Phase II/III study in 2 parts (i.e. Part 1 (dose rangi...
Status
Recruiting
Location
For additional information regarding investigative sites for this trial, contact SyneuRx International Corp.
A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation for Patients With Refractory Schizophrenia Treated With Clozapine
PHASE3
The primary outcome of this study is to evaluate the effects of low frequen...